Capital Asset Advisory Services’s Ascendis Pharma A/S ASND Stock Holding History

Capital Asset Advisory Services’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,443	Closed	-$549K	–	604
2021 Q3	$549K	Sell	3,443 -55	-2%	-$7.53K	0.06%	240
2021 Q2	$460K	Buy	3,498 +152	+5%	+$20.3K	0.05%	277
2021 Q1	$431K	Buy	3,346 +794	+31%	+$121K	0.06%	278
2020 Q4	$426K	Buy	2,552 +775	+44%	+$128K	0.08%	227
2020 Q3	$274K	Sell	1,777 -12	-0.7%	-$1.73K	0.06%	252
2020 Q2	$251K	Buy	1,789 +240	+15%	+$33K	0.05%	289
2020 Q1	$208K	Buy	+1,549	New	+$201K	0.06%	276

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital Asset Advisory Services's ASND Position: Q4 2021 in Review

Capital Asset Advisory Services sold out of Ascendis Pharma A/S (ASND) in Q4 2021, closing a stake of 3,443 shares — an estimated $549K sold.

Capital Asset Advisory Services first reported a position in ASND in Q1 2020 and held it in 7 quarters. The position peaked at $549K in Q3 2021. 172 funds tracked by Wall St. Rank hold ASND as of Q4 2021.

Capital Asset Advisory Services reported no remaining Ascendis Pharma A/S position as of Q4 2021 after selling out during the quarter.
Capital Asset Advisory Services sold 3,443 Ascendis Pharma A/S shares in Q4 2021, an estimated $549K.
Capital Asset Advisory Services first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 7 quarters.
Capital Asset Advisory Services's Ascendis Pharma A/S position peaked at $549K in Q3 2021.
172 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2021.

Based on Capital Asset Advisory Services's 13F filing for Q4 2021, filed 4 Feb 2022.